MarketInOut Stock Screener Log In | Sign Up

Fredun Pharmaceuticals Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:50
Fredun Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization25,148 mln
Float8.07 mln

EPS

27.53
Stretched

P / E

53.48
Richly valued

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-1.66
Likely manipulated

Relative Strength

76 / 100
Strongly outperforming

Debt / Equity

0.87
Moderate leverage

Business Description

Founded in 1987 and based in Mumbai, India, Fredun Pharmaceuticals Limited produces and distributes a broad range of health products across India and international markets including Africa, Southeast Asia, Latin America, and the Middle East. Its portfolio covers medicines for common and complex conditions, surgical supplies, animal health products, dietary supplements, and personal care items. The company also markets a dedicated brand focused on hormones, longevity, and human performance. Fredun serves both everyday healthcare needs and specialized therapeutic areas through its global distribution network.

Key Fundamentals

EPS27.53
P/E53.48
ROE22.79
RPS501
ROIC19.48
ROA8.25
Interest Cover2.41
EBITDA, mln1,103
EV / EBITDA22.76
EV / EBIT25.13
Revenue, mln7,475
EV / Revenue3.36

Quote Details

Last 1,472.20
Change 21.3 (1.47%)
Open 1,471.00
Volume 43,696
Turnover 64,329,248
Average Volume 151,269

Financial Ratios

Pre-Tax Profit Margin8
Current Ratio1.68
Price / Book8.59
Price / Tangible Book8.61
Debt / Equity0.87
Price / Sales3.13
PEG Ratio1.01

Financial Strength

Altman Z-Score5.98
Piotroski F-Score 4 / 9
Beneish M-Score-1.66
Price to Lynch Fair Value2.11
Price to Graham Number4.73
Shiller PE Ratio193

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 7.78% 95 / 100   
1 Month 8.52% 93 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog